Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

TCT 2021 | Challenges of treating elderly patients with ALL

Marc Schwartz • 8 Feb 2021
TCT 2021
Acute Lymphoblastic Leukemia Leukemia Blinatumomab

Marc Schwartz, MD, University of Colorado, Aurora, CO, explores challenges associated with the treatment of older patients with acute lymphoblastic leukemia (ALL), including chemotherapy-free approaches. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.

More from Marc Schwartz

1:48
Dasatinib prednisone induction prior to transplant for Ph+ ALL
Marc Schwartz • 8 Feb 2021

Related Videos

1:25
The role of the bone marrow microenvironment in hematological malignancies
Manja Wobus • 17 Apr 2024
2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:14
Promising novel agents in AML: menin inhibitors
Mark Levis • 16 Apr 2024
3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals